189 related articles for article (PubMed ID: 17006006)
41. The relationship between HAART use and employment for HIV-positive individuals: an empirical analysis and policy outlook.
Bernell SL; Shinogle JA
Health Policy; 2005 Feb; 71(2):255-64. PubMed ID: 15607387
[TBL] [Abstract][Full Text] [Related]
42. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
[TBL] [Abstract][Full Text] [Related]
43. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
Blanes M; Belinchón I; Portilla J
Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
[TBL] [Abstract][Full Text] [Related]
44. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
45. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
46. Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
Stephens JR; Rathbun RC; Lockhart SM; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Nov; 100(11):417-24. PubMed ID: 18183858
[TBL] [Abstract][Full Text] [Related]
47. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
48. Impact of depression on HIV outcomes in the HAART era.
Hartzell JD; Janke IE; Weintrob AC
J Antimicrob Chemother; 2008 Aug; 62(2):246-55. PubMed ID: 18456650
[TBL] [Abstract][Full Text] [Related]
49. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
[TBL] [Abstract][Full Text] [Related]
50. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
51. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
[TBL] [Abstract][Full Text] [Related]
52. The obstetric face and challenge of HIV/AIDS.
Guidozzi F; Black V
Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
[TBL] [Abstract][Full Text] [Related]
53. Current status of HIV infection: a review for non-HIV-treating physicians.
Knoll B; Lassmann B; Temesgen Z
Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
[TBL] [Abstract][Full Text] [Related]
54. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
Corona A; Raimondi F
Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
[TBL] [Abstract][Full Text] [Related]
55. Current developments in anti-HIV/AIDS gene therapy.
Tsygankov AY
Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
[TBL] [Abstract][Full Text] [Related]
56. How does HIV impact on non-AIDS events in the era of HAART?
Barber TJ; Hughes A; Dinsmore WW; Phillips A
Int J STD AIDS; 2009 Jan; 20(1):1-3. PubMed ID: 19103883
[TBL] [Abstract][Full Text] [Related]
57. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
58. [The methods of therapy ESRD patients infected with the human immunodeficiency virus-HIV].
Gozdowska J; Durlik M
Przegl Lek; 2008; 65(2):82-6. PubMed ID: 18663906
[TBL] [Abstract][Full Text] [Related]
59. Impact of antiretroviral therapy on vocational rehabilitation.
Ajithkumar K; Iype T; Arun KJ; Ajitha BK; Aveenlal KP; Antony TP
AIDS Care; 2007 Nov; 19(10):1310-2. PubMed ID: 18071977
[TBL] [Abstract][Full Text] [Related]
60. Twenty-five years of HIV/AIDS--United States, 1981-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jun; 55(21):585-9. PubMed ID: 16741493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
